Tetraph Pharma (TTPH) Misses Q2 EPS by 17c

Tetraph Pharma (NASDAQ: TTPH) reported Q2 EPS of ($0.71), $0.17 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $2.79 million.

For earnings history and earnings-related data on Tetraph Pharma (TTPH) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
• SPS Commerce (SPSC) Tops Q1 EPS by 12c